Pathological correlates of white matter hyperintensities in a case of progranulin mutation associated frontotemporal dementia

• Published in: Neurocase 2018-06, Vol.24 (3), p.166-174
• Main Authors: Woollacott, Ione O.C., Bocchetta, Martina, Sudre, Carole H., Ridha, Basil H., Strand, Catherine, Courtney, Robert, Ourselin, Sebastien, Cardoso, M. Jorge, Warren, Jason D., Rossor, Martin N., Revesz, Tamas, Fox, Nick C., Holton, Janice L., Lashley, Tammaryn, Rohrer, Jonathan D.
• Format: Article
• Language: English
• Subjects: Atrophy; Attention deficit hyperactivity disorder; Brain; Cadavers; Cortex; Dementia; Dementia disorders; Demyelination; Dystrophy; Female; Frontotemporal dementia; Frontotemporal Dementia - diagnostic imaging; Frontotemporal Dementia - genetics; Frontotemporal Dementia - pathology; Frontotemporal Dementia - physiopathology; Gliosis; Haploinsufficiency; Humans; Image processing; Immunohistochemistry; Localization; Magnetic resonance imaging; microglia; Middle Aged; MRI; Mutation; Myelin; Neurodegeneration; neuroinflammation; Pathology; progranulin; Progranulins - genetics; Segmentation; Substantia alba; white matter; White Matter - diagnostic imaging; White Matter - pathology
• ISSN: 1355-4794; 1465-3656; 1362-4970
• DOI: 10.1080/13554794.2018.1506039

White matter hyperintensities (WMH) are often seen on MRI brain scans in frontotemporal dementia (FTD) due to progranulin (GRN) mutations, but their pathological correlates are unknown. We examined the histological changes underlying WMH in a patient with GRN mutation associated behavioral variant FTD. In vivo and cadaveric MRI showed progressive, asymmetric frontotemporal and parietal atrophy, and asymmetrical WMH predominantly affecting frontal mid-zones. We first performed segmentation and localization analyses of WMH present on cadaveric MRI FLAIR images, then selected five different brain regions directly matched to differing severities of WMH for histological analysis. We used immunohistochemistry to assess vascular pathology, degree of spongiosis, neuronal and axonal loss, TDP-43, demyelination and astrogliosis, and microglial burden and morphology. Brain regions with significant WMH displayed severe cortical and white matter pathology, and prominent white matter microglial activation and microglial dystrophy, but only mild axonal loss and minimal vascular pathology. Our study suggests that WMH in GRN mutation carriers are not secondary to vascular pathology. Whilst cortical pathology induced axonal degeneration could contribute to white matter damage, individuals with GRN mutations could develop selective white matter vulnerability and myelin loss due to chronic, regional microglial dysfunction arising from GRN haploinsufficiency.